Effects of co-administered ezetimibe and fenofibrate in mixed dyslipidaemic patients with metabolic syndrome

被引：0
|
作者：
Davies, M. J.
Bays, H. E.
Shah, A.
Macdonell, G.
Gumbiner, B.
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] LMARC, Clin Res, Louisville, KY USA
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0746
引用
收藏
页码：452 / 453
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of coadministered ezetimibe and fenofibrate in patients with mixed hyperlipidemia
    Farnier, M
    Freeman, M
    Macdonell, G
    Perevozskaya, I
    Davies, M
    Mitchel, Y
    Gumbiner, B
    DIABETOLOGIA, 2004, 47 : A408 - A408
  • [22] Efficacy and safety of coadministered fenofibrate and ezetimibe in patients with mixed hyperlipidemia
    Freeman, MW
    Fanier, M
    Bays, HE
    Macdonell, G
    Davies, MJ
    Mitchel, Y
    Gumbiner, B
    CIRCULATION, 2004, 110 (17) : 117 - 117
  • [23] Effects of co-administered heparin in preterm infants
    Kettnee, SC
    Kuhle, S
    Seibt, FA
    Panzer, OP
    Pollak, A
    Zimpfer, M
    BRITISH JOURNAL OF ANAESTHESIA, 1999, 82 : 148 - 148
  • [24] Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: Efficacy and safety of ezetimibe co-administered with atorvastatin
    Stein, E
    Stender, S
    Mata, P
    Sager, P
    Ponsonnet, D
    Melani, L
    Lipka, L
    Suresh, R
    MacCubbin, D
    Veltri, E
    AMERICAN HEART JOURNAL, 2004, 148 (03) : 447 - 455
  • [25] Metabolic effects of co-administered simvastatin and ω-3 polyunsaturated fatty acids in type 2 diabetic patients with cardiomyopathy
    Serhiyenko, V. A.
    Urbanovich, A. M.
    Serhiyenko, A. A.
    DIABETOLOGIA, 2007, 50 : S492 - S492
  • [26] Beneficial effects of ezetimibe on visceral fat in patients with metabolic syndrome
    Takase, H.
    Dohi, Y.
    Toriyama, T.
    Okado, T.
    Sonoda, H.
    Hagikura, A.
    Goto, Y.
    Hashimoto, T.
    Kimura, G.
    EUROPEAN HEART JOURNAL, 2011, 32 : 684 - 684
  • [27] Beneficial effects of ezetimibe on visceral fat in patients with metabolic syndrome
    Takase, H.
    Dohi, Y.
    Toriyama, T.
    Okado, T.
    Sonoda, H.
    Hagikura, A.
    Goto, Y.
    Hashimoto, T.
    Kimura, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 : 684 - 684
  • [28] Anti-inflammatory effects of fenofibrate in metabolic syndrome patients
    Rosenson, RS
    Huskin, AL
    Wolff, DA
    DIABETES, 2005, 54 : A146 - A146
  • [29] Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome
    Wysocki, J
    Belowski, D
    Kalina, M
    Kochanski, L
    Okopien, B
    Kalina, Z
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2004, 42 (04) : 212 - 217
  • [30] Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia
    McKenney, JM
    Farnier, M
    Lo, KW
    Bays, HE
    Perevozkaya, I
    Carlson, G
    Davies, MJ
    Mitchel, YB
    Gumbiner, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1584 - 1587
12345